Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
View Study [4]"Inhibition of activin-like kinase 4/5 attenuates cancer cachexia associated muscle wasting" Levolger S, Wiemer EAC, et al., 2019 Finding: LR3 IGF-I treatment effectively limited muscle mass loss in a cancer cachexia model, demonstrating its potent anti-catabolic effects and ability to preserve muscle tissue under conditions that normally cause severe muscle wasting
Evening dosing is preferred because it aligns with the bodys natural circadian rhythm of growth hormone release, which peaks at night during deep sleep
Adverse Events Of the 15 trials, four did not report adverse event (AE) data
The levels of messenger RNA (mRNA) related to liver urea cycle enzymes were scrutinized, alongside an assessment of the overall nitrogen balance and a hypothesis regarding nitrogen distribution across various organs
Yes, it is generally safe when administered under medical supervision using appropriate dosage and quality-controlled formulations
